Spiromesifen

• Description:

  Spiromesifen (BSN 2060) is a broad-spectrum tetrachloro acid derivative acaricide. Spiromesifen reduces lipid biosynthesis via inhibition of acetyl-CoA carboxylase, and has no cross-resistance to any resistant mite or whitefly populations[1].

• Product Name Alternative:

  BSN 2060

• UNSPSC:

  12352005

• Hazard Statement:

  H317, H410

• Target:

  Acetyl-CoA Carboxylase; Drug Derivative

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease; Others

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/spiromesifen.html

• Purity:

  97.20

• Solubility:

  DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles:

  CC1=C(C(C)=CC(C)=C1)C2=C(C3(OC2=O)CCCC3)OC(CC(C)(C)C)=O

• Molecular Formula:

  C23H30O4

• Molecular Weight:

  370.48

• Precautions:

  H317, H410

• References & Citations:

  [1]Bretschneider T, et al. Spirodiclofen and spiromesifen–novel acaricidal and insecticidal tetronic acid derivatives with a new mode of action[J]. Chimia, 2003, 57 (11) : 697-697.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  283594-90-1